Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlkemy Capital. Regulatory News (ALK)

Share Price Information for Alkemy Capital. (ALK)

Share Price is delayed by 15 minutes
Get Live Data
218.00    -17.00 (-7.02%)
Bid:
221.00
Ask:
229.00
Spread: 8.00 (3.62%)
Market Cap: £23.93m
ALK Live PriceLast checked at - London Stock Exchange

Intraday Alkemy Capital. Share Chart

Holding(s) in Company

17 Jul 2008 10:25

RNS Number : 2793Z
Alkane Energy PLC
17 July 2008
Β 

ο»Ώ

Alkane Energy plc

17 JulyΒ 2008

TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedΒ (ii):

Alkane Energy GB0003286613

2.Β Reason for the notificationΒ (please state Yes/No):

An acquisition or disposal of voting rights:Β No

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached:Β No

An event changing the breakdown of voting rights:Β Yes

Other (please specify):Β No

3. Full name of person(s) subject to the notification obligation (iii):

UBS Investment Bank

4. Full name of shareholder(s)Β (if different from 3.)Β (iv):

UBS AGΒ LondonΒ Branch

5. Date of the transactionΒ (and date on which the threshold is crossed or reachedΒ if different)Β (v):

14 July 2008

6. Date on which issuer notified:

16 July 2008

7. Threshold(s) that is/are crossed or reached:

8.99%

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

If possible using the ISIN code

Situation previous to the triggering transactionΒ vi

Resulting situation after the triggering transactionΒ vii

Number of shares

Number of voting rights

% voting rights

Number of shares

Number of voting rightsΒ viii

Direct

DirectΒ x

IndirectΒ xi

Direct

Indirect

GB0003286613

8,349,971

8,349,971

8,349,971

8,349,971

-

8.99%

-

B: Financial Instruments

Resulting situation after the triggering transactionΒ xii

Type of financial

instrument

Expiration dateΒ xiii

Exercise/Conversion Period/DateΒ xiv

Number of voting rights that may be acquired if thisΒ instrument is exercised/converted

% voting rights

-

-

-

-

-

Total (A+B)

Number of voting rights

%Β of voting rights

8,349,971

8.99%

9.Β Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicableΒ (xv):

N/A

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

N/A

14. Contact name:

Cintia Goertz/Sarah Cottie

15. Contact telephone number:

0207 5684981

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
HOLGUUCPMUPRUBM
Date   Source Headline
28th May 20267:00 amRNSAnnual Report & Financial Statements
24th Apr 20267:00 amRNSTVL Project Development Update
19th Mar 20267:00 amRNSTVL Industry Engagement Update
27th Feb 20263:00 pmRNSLoan Conversion
24th Feb 20267:00 amRNSTVL Appoints Wates group
12th Feb 20267:00 amRNSTVL Advances On-Site Lithium Recovery
5th Feb 20263:26 pmRNSGrant of Share Awards
3rd Feb 20267:00 amRNSTVL FEED Study
29th Jan 20264:07 pmRNSLoan Conversion
28th Jan 20269:35 amRNSTVL and Glencore Sign Binding Offtake Agreement
14th Jan 20267:00 amRNSTVL FEED Study Update
9th Dec 202511:40 amRNSLoan Conversion
27th Nov 20253:00 pmRNSExercise of Warrants and Loan Conversion
10th Nov 20257:00 amRNSTees Valley Lithium Financing and Project Delivery
5th Nov 20257:00 amRNSAppointment of ABG Sundal Collier ASA
3rd Nov 20251:28 pmRNSExercise of Warrants
29th Oct 20254:23 pmRNSExercise of Warrants
15th Oct 20257:00 amRNSInterim Results
9th Oct 20257:00 amRNSTVL: Appointment of COO & Launch of OEP
6th Oct 20257:00 amRNSTVL: Lower CAPEX, Higher Uptime, Stronger Outlook
29th Aug 20257:00 amRNSTVL Project and Leadership Update
31st Jul 20253:00 pmRNSExercise of Warrants
31st Jul 20257:00 amRNSFEED Funding and Equity Funding Proposal
17th Jul 20257:00 amRNSTVL Secures Binding Feedstock Agreement
25th Jun 20257:00 amRNSOversubscribed Subscription to raise £500,000
18th Jun 20251:00 pmRNSResult of AGM
2nd Jun 20257:05 amRNSAlkemy Shareholder Call
2nd Jun 20257:00 amRNSTVL Update: Process Validated, CAPEX Confirmed
23rd May 20253:00 pmRNSNotice of AGM
21st May 20254:30 pmRNSFinal Results
12th May 20257:05 amRNS-RAlkemy Shareholder Call
12th May 20257:00 amRNSExclusivity Agreement Signed with Ara Partners
18th Mar 20257:00 amRNSTVL - Exclusive Negotiation for Lithium Supply
18th Feb 20257:00 amRNSTVL Appoints New CEO and Commences FEED Study
17th Feb 20258:27 amRNSReplacement: Subscription to raise £0.75 million
17th Feb 20257:00 amRNSPlacing to raise £1.035 million
31st Jan 20257:00 amRNSTVL Collaborates with Veolia
6th Nov 20247:00 amRNSChairman Share Purchases
24th Oct 20248:00 amRNSABG Sundal Collier to lead US$25m Convertible Bond
2nd Oct 20247:00 amRNSInterim Results
5th Aug 20247:00 amRNSCorporate Update
2nd Jul 20242:00 pmRNSResult of AGM
5th Jun 20244:30 pmRNSNotice of AGM
30th May 20244:30 pmRNSAnnual Report & Financial Statements
26th Feb 20247:00 amRNSChange of Adviser
30th Jan 20247:00 amRNSMOU with Syrah for UK’s first Graphite refinery
18th Jan 20247:00 amRNSCorporate Update
18th Dec 20237:00 amRNSOversubscribed Placing to raise £650,000
4th Dec 20237:00 amRNSTVL Secures Technology and Vendor Partnerships
20th Nov 20237:00 amRNSAppointment of Battery Metals Supply Chain Expert

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.